Header Ads Widget

Responsive Advertisement

Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles


By SPARTA NEWS Health A group of Alzheimer’s experts and health advocates called on the F.D.A. to withdraw its approval of the drug, the latest of several setbacks for the treatment. BY PAM BELLUCK Health New York Times December 20, 2021 at 11:25PM

Post a Comment

0 Comments

>